Key facts
- It has raised $53.6M; the latest was Accelerator/Incubator in Jan 2025.
- Notable investors include Endeavor Catalyst, Gates Foundation, Cercano Management, Susquehanna Growth Equity, Johnson & Johnson Services — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for SwipeRx
- ·The full record, as it builds
Funding rounds
No funding rounds for SwipeRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SwipeRx
Developer of a medical technology system designed to connect pharmaceutical manufacturers, pharmacies, and patients. The company's system generates insights to facilitate more effective collaboration with pharmacies, enhances pharmacist education, strengthens market access, optimizes commercial strategies, improves day-to-day operational efficiencies, and provides real-time access to patient and sales data, enabling clients to advance patient affordability, access, and adherence.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2012
- Employees
- 279
- Website
- swiperx.com/
- Ownership
- Privately Held (backing)
SwipeRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SwipeRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SwipeRx in its N-PORT filings yet. We sweep new filings monthly.